AstraZeneca | AstraZeneca | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
Eisai | Eisai | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
Eli Lilly | Eli Lilly | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
Gilead Sciences | Gilead Sciences | False Claims Act and related | 2013 | LA-AG | $250,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | MA-AG | $15,100,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
Lupin Pharmaceuticals | Lupin Limited | False Claims Act and related | 2013 | LA-AG | $750,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Merck | Merck | drug or medical equipment safety violation | 2013 | PA-AG | $8,250,000 |
Mylan Specialty L.P. | Viatris | consumer protection violation | 2013 | OR-AG | $250,000 |
Mylan Specialty, L.P. | Viatris | off-label or unapproved promotion of medical products | 2013 | MA-AG | $250,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2013 | ID-AG | $750,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
Pernix Therapeutics | Currax Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MA-AG | $375,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
Ranbaxy | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
Sanofi US Services, Inc. | Sanofi | kickbacks and bribery | 2013 | MULTI-AG | $617,000 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
UCB | UCB | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | air pollution violation | 2013 | IN-ENV | $20,000 |
E R SQUIBB & SONS LLC | Bristol-Myers Squibb | air pollution violation | 2013 | NJ-ENV | $5,950 |
GlaxoSmithKline, LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
DePuy Orthopaedics, Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $288,000,000 |
Abbott Cardiovascular Systems, Inc. | Abbott Laboratories | air pollution violation | 2013 | CA-SCAQMD | $93,700 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $35,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $150,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
Neutrogena Corporation | Johnson & Johnson | consumer protection violation | 2013 | private lawsuit-federal | $1,800,000 |
Merck & Co. | Merck | consumer protection violation | 2013 | private lawsuit-federal | $10,000,000 |
AMGEN SF, LLC | Amgen | workplace safety or health violation | 2013 | OSHA | $5,400 |
AAIPHARMA SERVICES CORP. | Alcami | workplace safety or health violation | 2013 | OSHA | $11,550 |
NOVARTIS CONSUMER HEALTH INC. | Novartis | workplace safety or health violation | 2013 | OSHA | $6,078 |
ANIKA THERAPEUTICS INC. | Anika Therapeutics | workplace safety or health violation | 2013 | OSHA | $5,800 |
EMD MILLLIPORE CORP | Merck KGaA (EMD) | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
Celgene Corporation | Bristol-Myers Squibb | PCB violation | 2013 | EPA | $6,035 |
KING PHARMACEUTICALS | Pfizer | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
MALLINCKRODT, LLC | Mallinckrodt | hazardous waste violation | 2013 | EPA | $449,740 |
Endo Health Solutions Inc. | Endo International | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
GlaxoSmithKline Vaccines | GlaxoSmithKline | air pollution violation | 2014 | EPA | $172,900 |
GlaxoSmithKline LLC | GlaxoSmithKline | hazardous waste violation | 2014 | EPA | $317,550 |
Advanced Sterilization Products | Johnson & Johnson | environmental violation | 2014 | EPA | $136,800 |
Pfizer Pharmaceuticals LLC | Pfizer | air pollution violation | 2014 | EPA | $728,000 |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | tax violations | 2014 | ATTTB | $506,035 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
InterMune Inc. | Roche | Family and Medical Leave Act | 2014 | WHD | $59,085 |
Perrigo Company | Perrigo | Family and Medical Leave Act | 2014 | WHD | $15,022 |
BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | aviation safety violation | 2014 | FAA | $15,000 |
GLAXO SMITH KLINE | GlaxoSmithKline | aviation safety violation | 2014 | FAA | $59,500 |
Mylan | Viatris | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,100,000 |
DePuy Orthopaedics Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
Endo Health Solution | Endo International | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
Organon | Organon & Co. | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $31,000,000 |
Pfizer | Pfizer | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
Ranbaxy Laboratories | Sun Pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
Ranbaxy Pharmaceuticals, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2014 | PA-ENV | $12,270 |
Biocryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | hazardous waste violation | 2014 | AL-ENV | $11,000 |
Mia Rose, Inc. | Nutraceutical International Corp. | air pollution violation | 2014 | CA-ARB | $45,000 |
Neutrogena Corp. | Johnson & Johnson | environmental violation | 2014 | CA-DTSC | $416,248 |
SIGMA-ALDRICH MANUFACTURING | Merck KGaA (EMD) | environmental violation | 2014 | IL-ENV | $12,500 |
ALCAMI CORPORATION | Alcami | hazardous waste violation | 2014 | NJ-ENV | $11,900 |
AMRI Rensselaer, Inc. | Curia Inc. | environmental violation | 2014 | NY-ENV | $45,000 |
Mallinckrodt LLC | Mallinckrodt | environmental violation | 2014 | NY-ENV | $7,499 |
Boehringer Ingelheim International | Boehringer Ingelheim | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
Endo International PLC | Endo International | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $830,000,000 |
Merck | Merck | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $27,700,000 |